Dudediligence.

Oncolytics Biotech Inc

ONCYNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

124.6M

on 2026-06-30, from 108.0M on 2025-12-31 10-Q ↗

50M100MDec2025Mar2026Jun

Newest

$250.0M

S-3 of 2026-04-01. 1 prospectus supplement filed under it since. S-3 ↗

$75.0M

Jefferies, agreement of 2025-10-17. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

7.67M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

Four quarters of operating cash flow to 2026-06-30 are not all on file.

Raised: 1 of its filings are not read yet.